We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$4.93B
AUM Growth
+$634M
Cap. Flow
+$193M
Cap. Flow %
3.91%
Top 10 Hldgs %
46.72%
Holding
190
New
7
Increased
53
Reduced
59
Closed
11

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$17.4M
2
AJG icon
Arthur J. Gallagher & Co
AJG
+$13.1M
3
RUSHA icon
Rush Enterprises Class A
RUSHA
+$11.4M
4
CACC icon
Credit Acceptance
CACC
+$10.8M
5
OWL icon
Blue Owl Capital
OWL
+$10.2M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$6.79M
2
TCN
Tricon Residential Inc.
TCN
+$6.04M
3
SHW icon
Sherwin-Williams
SHW
+$3.09M
4
AAPL icon
Apple
AAPL
+$2.49M
5
JEF icon
Jefferies Financial Group
JEF
+$1.82M

Sector Composition

Rank Sector Weight
1 Financials 40.58%
2 Healthcare 13.65%
3 Technology 12.84%
4 Industrials 7.53%
5 Communication Services 6.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LIN icon
76
Linde
LIN
$236B
$3.19M 0.06%
6,875
– –
V icon
77
Visa
V
$701B
$3.03M 0.06%
10,848
+1,312
+14% +$362K
GLD icon
78
SPDR Gold Trust
GLD
$131B
$2.57M 0.05%
12,475
– –
GL icon
79
Globe Life
GL
$14B
$2.46M 0.05%
21,125
– –
PFE icon
80
Pfizer
PFE
$143B
$2.44M 0.05%
88,000
– –
IVV icon
81
iShares Core S&P 500 ETF
IVV
$858B
$2.22M 0.04%
4,217
– –
DE icon
82
Deere & Co
DE
$165B
$2.14M 0.04%
5,200
– –
DHR icon
83
Danaher
DHR
$138B
$1.98M 0.04%
7,940
-1,808
-19% -$441K
CVX icon
84
Chevron
CVX
$382B
$1.88M 0.04%
11,906
-100
-0.8% -$15.1K
SLB icon
85
SLB Ltd
SLB
$72.7B
$1.79M 0.04%
32,700
-300
-0.9% -$15.1K
BNY
86
Bank of New York Mellon
BNY
$103B
$1.72M 0.03%
29,815
-565
-2% -$31.1K
BAX icon
87
Baxter International
BAX
$12.8B
$1.71M 0.03%
39,985
-5,311
-12% -$216K
CVS icon
88
CVS Health
CVS
$135B
$1.68M 0.03%
21,039
-300
-1% -$22.9K
DOX icon
89
Amdocs
DOX
$6.03B
$1.57M 0.03%
17,336
+81
+0.5% +$7.38K
GE icon
90
GE Aerospace
GE
$364B
$1.45M 0.03%
10,352
-32
-0.3% -$3.77K
EW icon
91
Edwards Lifesciences
EW
$49.4B
$1.44M 0.03%
15,120
– –
MTD icon
92
Mettler-Toledo International
MTD
$28.1B
$1.38M 0.03%
1,040
-200
-16% -$247K
HES
93
DELISTED
Hess
HES
$1.37M 0.03%
9,000
– –
TJX icon
94
TJX Companies
TJX
$179B
$1.37M 0.03%
13,521
+4,474
+49% +$434K
CNI icon
95
Canadian National Railway
CNI
$78.5B
$1.32M 0.03%
10,050
-50
-0.5% -$6.39K
NDSN icon
96
Nordson
NDSN
$16.4B
$1.32M 0.03%
4,800
– –
VOO icon
97
Vanguard S&P 500 ETF
VOO
$956B
$1.3M 0.03%
2,705
-156
-5% -$71.4K
AMGN icon
98
Amgen
AMGN
$209B
$1.3M 0.03%
4,568
+89
+2% +$26K
IDXX icon
99
Idexx Laboratories
IDXX
$44.9B
$1.28M 0.03%
2,375
+250
+12% +$137K
RNR icon
100
RenaissanceRe
RNR
$13.8B
$1.15M 0.02%
4,900
– –
2 3
4
5 6

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q1 2024 Portfolio in Review

As of Q1 2024, Beck Mack & Oliver held 190 positions worth $4.93B, up 15% from $4.3B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Beck Mack & Oliver deployed $193M of net new capital in Q1 2024, opening 7 new positions and adding to 53 existing holdings. Its largest new stake was Smith Douglas Homes: 142,029 shares worth $4.22M.

By sector, the portfolio is most concentrated in Financials at 41% of assets, down from 41% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $6.79M trimmed.

  • Beck Mack & Oliver's largest Q1 2024 buy was Smith Douglas Homes: 142,029 shares worth $4.22M.
  • Beck Mack & Oliver added most to Amazon in Q1 2024, an estimated $17.4M increase.
  • Beck Mack & Oliver's biggest Q1 2024 reduction was Teva Pharmaceuticals, cutting an estimated $6.79M.
  • Beck Mack & Oliver fully exited Blue Owl Capital in Q1 2024, selling an estimated $502K.
  • Beck Mack & Oliver's ten largest holdings make up 47% of its $4.93B portfolio in Q1 2024.
  • Beck Mack & Oliver opened 7 new positions and closed 11 in Q1 2024.
  • Beck Mack & Oliver's portfolio value rose 15% quarter-over-quarter to $4.93B.

Based on Beck Mack & Oliver's 13F filing for Q1 2024, filed 14 May 2024.